ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,490 | -84.9% | 26,653 | -76.4% | 0.00% | – |
| Q2 2023 | $561,128 | +88.1% | 112,903 | +86.9% | 0.00% | – |
| Q1 2023 | $298,381 | +370.0% | 60,401 | +498.4% | 0.00% | – |
| Q4 2022 | $63,491 | -96.4% | 10,094 | -93.9% | 0.00% | -100.0% |
| Q3 2022 | $1,782,000 | +85.4% | 165,007 | +95.7% | 0.00% | – |
| Q2 2022 | $961,000 | +76.0% | 84,301 | +40.8% | 0.00% | – |
| Q1 2022 | $546,000 | -72.8% | 59,865 | -55.4% | 0.00% | – |
| Q4 2021 | $2,004,000 | +133.6% | 134,313 | +302.7% | 0.00% | – |
| Q3 2021 | $858,000 | +86.9% | 33,354 | +89.5% | 0.00% | – |
| Q2 2021 | $459,000 | +9.3% | 17,600 | +48.0% | 0.00% | – |
| Q1 2021 | $420,000 | -44.2% | 11,895 | -60.2% | 0.00% | – |
| Q4 2020 | $753,000 | -33.4% | 29,858 | -0.4% | 0.00% | -100.0% |
| Q3 2020 | $1,130,000 | -16.0% | 29,977 | -4.5% | 0.00% | 0.0% |
| Q2 2020 | $1,345,000 | +80.8% | 31,405 | +15.1% | 0.00% | 0.0% |
| Q3 2019 | $744,000 | – | 27,295 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |